Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus.
Celeghini
Claudio
C
Bortul
Roberta
R
Fadda
Roberto
R
Gonelli
Arianna
A
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000502:physiology; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000503:physiopathology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000494:pharmacology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; D014665:Vasodilator Agents